Understanding the Role of Protein CYP2E1
Regulation and Consequences of Cytochrome P450 2E1
This research aims to understand how a special protein called CYP2E1 works in the body and what happens when it is active, which could help us develop safer treatments for liver damage and other health issues.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Medical University of South Carolina NIH-funded |
| Lab location | 1 site (Charleston, United States) |
| Project ID | NIH-11106041 on NIH RePORTER |
What this research studies
Our bodies have a unique protein called CYP2E1 that plays an important role, but we don't fully understand how it works or what its natural job is. While some studies suggest that blocking this protein might help with conditions like liver damage or epilepsy, we need to learn more about its normal functions before we can safely use it as a treatment. This project will explore how CYP2E1 is controlled and what it does inside our cells, especially in the liver. By filling these knowledge gaps, we hope to pave the way for new and safer ways to help people with various health problems.
Who could benefit from this research
Good fit: This foundational research is for future patients who might benefit from treatments for conditions like alcoholic liver damage, nonalcoholic fatty liver disease, or epilepsy.
Not a fit: Patients seeking immediate clinical interventions or direct participation in a treatment trial would not directly benefit from this basic science research.
Why it matters
Potential benefit: If successful, this work could lead to a better understanding of liver diseases and other conditions, potentially allowing for the development of safer and more effective treatments that target the CYP2E1 protein.
How similar studies have performed: While some studies suggest CYP2E1 inhibition could be protective, there are major gaps in understanding its endogenous function, making this research foundational and addressing previously unanswered questions.
Where this research is happening
Charleston, United States
- Medical University of South Carolina — Charleston, United States (Active)
Researchers
- Principal investigator: Hartman, Jessica Helene — Medical University of South Carolina
- Study coordinator: Hartman, Jessica Helene
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.